DK0950053T3 - Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater - Google Patents
Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivaterInfo
- Publication number
- DK0950053T3 DK0950053T3 DK97953948T DK97953948T DK0950053T3 DK 0950053 T3 DK0950053 T3 DK 0950053T3 DK 97953948 T DK97953948 T DK 97953948T DK 97953948 T DK97953948 T DK 97953948T DK 0950053 T3 DK0950053 T3 DK 0950053T3
- Authority
- DK
- Denmark
- Prior art keywords
- benzoylalkyl
- new
- tetrahydropyridine derivatives
- compounds
- formula
- Prior art date
Links
- 150000008083 1,2,3,6-tetrahydropyridines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000018152 Cerebral disease Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9615957A FR2757512B1 (fr) | 1996-12-24 | 1996-12-24 | Utilisation de benzoylalkyl-1-1,2,3,6-tetrahydropyridines |
| PCT/FR1997/002424 WO1998028274A1 (fr) | 1996-12-24 | 1997-12-24 | Utilisation de benzoylalkyl-1,2,3,6-tetrahydropyridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0950053T3 true DK0950053T3 (da) | 2003-09-29 |
Family
ID=9499090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97953948T DK0950053T3 (da) | 1996-12-24 | 1997-12-24 | Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US6358965B1 (da) |
| EP (1) | EP0950053B1 (da) |
| JP (1) | JP2001513077A (da) |
| AT (1) | ATE242766T1 (da) |
| AU (1) | AU5768298A (da) |
| BR (1) | BR9714184A (da) |
| CA (1) | CA2272453A1 (da) |
| DE (1) | DE69722816T2 (da) |
| DK (1) | DK0950053T3 (da) |
| ES (1) | ES2200218T3 (da) |
| FR (1) | FR2757512B1 (da) |
| NO (1) | NO325140B1 (da) |
| PT (1) | PT950053E (da) |
| WO (1) | WO1998028274A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2459146A1 (en) * | 2001-08-30 | 2003-03-13 | Ortho-Mcneil Pharmaceutical, Inc. | Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors |
| JP5856212B2 (ja) | 2014-03-19 | 2016-02-09 | ファナック株式会社 | 工作機械の工具に対してワークを回転可能に支持する治具及び加工システム |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU208118B (en) * | 1989-12-01 | 1993-08-30 | Richter Gedeon Vegyeszet | Process for producing tetrahydropyridine derivatives and pharmaceutical compositions comprising such compounds |
| FR2662355B1 (fr) | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
| US5512584A (en) * | 1991-04-16 | 1996-04-30 | Basf Aktiengesellschaft | 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof |
| HU211019B (en) * | 1991-12-02 | 1995-09-28 | Richter Gedeon Vegyeszet | Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds |
-
1996
- 1996-12-24 FR FR9615957A patent/FR2757512B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-24 JP JP52849498A patent/JP2001513077A/ja not_active Ceased
- 1997-12-24 AU AU57682/98A patent/AU5768298A/en not_active Abandoned
- 1997-12-24 BR BR9714184-4A patent/BR9714184A/pt not_active Application Discontinuation
- 1997-12-24 PT PT97953948T patent/PT950053E/pt unknown
- 1997-12-24 ES ES97953948T patent/ES2200218T3/es not_active Expired - Lifetime
- 1997-12-24 CA CA002272453A patent/CA2272453A1/fr not_active Abandoned
- 1997-12-24 EP EP97953948A patent/EP0950053B1/fr not_active Expired - Lifetime
- 1997-12-24 US US09/331,524 patent/US6358965B1/en not_active Expired - Fee Related
- 1997-12-24 DE DE69722816T patent/DE69722816T2/de not_active Expired - Fee Related
- 1997-12-24 AT AT97953948T patent/ATE242766T1/de not_active IP Right Cessation
- 1997-12-24 WO PCT/FR1997/002424 patent/WO1998028274A1/fr not_active Ceased
- 1997-12-24 DK DK97953948T patent/DK0950053T3/da active
-
1999
- 1999-06-23 NO NO19993126A patent/NO325140B1/no unknown
-
2001
- 2001-11-20 US US10/044,221 patent/US20020058672A1/en not_active Abandoned
-
2003
- 2003-12-05 US US10/729,313 patent/US6936621B2/en not_active Expired - Fee Related
-
2005
- 2005-05-24 US US11/135,998 patent/US7151107B2/en not_active Expired - Fee Related
-
2006
- 2006-11-01 US US11/555,309 patent/US7297799B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69722816T2 (de) | 2004-05-13 |
| US6936621B2 (en) | 2005-08-30 |
| BR9714184A (pt) | 2000-02-29 |
| ES2200218T3 (es) | 2004-03-01 |
| FR2757512A1 (fr) | 1998-06-26 |
| US20050222187A1 (en) | 2005-10-06 |
| US7297799B2 (en) | 2007-11-20 |
| WO1998028274A1 (fr) | 1998-07-02 |
| US6358965B1 (en) | 2002-03-19 |
| NO993126D0 (no) | 1999-06-23 |
| NO993126L (no) | 1999-06-23 |
| ATE242766T1 (de) | 2003-06-15 |
| US7151107B2 (en) | 2006-12-19 |
| US20040122032A1 (en) | 2004-06-24 |
| DE69722816D1 (de) | 2003-07-17 |
| EP0950053A1 (fr) | 1999-10-20 |
| NO325140B1 (no) | 2008-02-11 |
| PT950053E (pt) | 2003-10-31 |
| JP2001513077A (ja) | 2001-08-28 |
| FR2757512B1 (fr) | 1999-03-12 |
| AU5768298A (en) | 1998-07-17 |
| US20020058672A1 (en) | 2002-05-16 |
| US20070054931A1 (en) | 2007-03-08 |
| CA2272453A1 (fr) | 1998-07-02 |
| EP0950053B1 (fr) | 2003-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000047568A3 (en) | 1,2-benzothiazepines for the treatment of hyperlipidemic diseases | |
| MY128659A (en) | Novel aminodicarboxylic acid derivatives having pharmaceutical properties | |
| CA2258548A1 (en) | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases | |
| HUT68357A (en) | Heterocyclic-cyclic-amine derivatives, pharmaceutical compositions containing them and process for their production | |
| MY106280A (en) | Novel benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use. | |
| HUP9802762A2 (hu) | Difenil-metilén-piperidin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk | |
| BG101715A (bg) | Тетрациклени спиросъединения,метод за тяхното получаване и приложението им като 5нт долу 1d рецепторни антагонисти | |
| MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
| HUP0200284A3 (en) | 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders, process for their preparation and pharmaceutical compositions containing them | |
| DE3480053D1 (en) | A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor | |
| DK0579996T3 (da) | 5,10-Methylentetrahydrofolsyrecyclodextrin-inklusionsforbindelser | |
| BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
| BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
| HUT50325A (en) | Process for producing bisphenylalkyl piperazine derivatives and pharmaceutical compositions comprising same as active ingredient | |
| IL109076A0 (en) | Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them | |
| DE59010302D1 (de) | R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel | |
| SE9702716D0 (sv) | Substituted phenylazacycloalkanes in the treatment of cognitive disorders | |
| DK0950053T3 (da) | Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater | |
| ZA905932B (en) | 14,17alpha-etheno-and-ethanoestratrienes,processes for the preparation of these compounds,as well as their use for the production of medicinal agents | |
| ES2009689A6 (es) | Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima. | |
| ES2184285T3 (es) | Compuestos farmaceuticos que contienen diclorhidrato de cinconina. | |
| IL111922A (en) | Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylates their preparation and pharmaceutical compositions containing them | |
| IL106934A (en) | Heteroarenylpiperazines a process for their preparation and pharmaceutical compositions comprising them | |
| RU93045455A (ru) | Производные пиперидина, способ их получения и фармацевтическая композиция на их основе | |
| ITMI931174A0 (it) | Composizioni farmaceutiche per la cura della talassemia |